Funded Tech Companies

Ambros Therapeutics

Ambros Therapeutics, based in Irvine, has financial backing from Balyasny Asset Management, Adage Capital Management and Arkin Bio-Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Ambros Therapeutics, headquartered in Irvine, California, is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases with a high unmet medical need. Our lead investigational program targets complex regional pain syndrome type 1 (CRPS-1), a devastating rare metabolic bone disease that causes severe, unrelenting and frequently lasting pain following trauma to the bone or an injury. Patients may experience significant functional loss, sleep disturbance, and meaningful diminished quality of life and independence.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/16/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Joseph Hagan

        

Company Investors

• Balyasny Asset Management
• Adage Capital Management
• Arkin Bio-Ventures
• Enavate Sciences
• RA Capital Management (Matthew Hammond)
• Transhuman Capital
• Janus Henderson Investors

Browse more funded tech companies:

Ambrook | Ambrosia Biosciences

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary